We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

78 hedge funds and large institutions have $210M invested in Arcus Biosciences in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

533% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 3

125% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 12

22% more funds holding

Funds holding: 64 → 78 (+14)

1.44% more ownership

Funds ownership: 57.92% → 59.37% (+1.4%)

35% less capital invested

Capital invested by funds: $322M → $210M (-$112M)

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
78
Holders Change
+14
Holders Change %
+21.88%
% of All Funds
1.69%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
19
Increased
27
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
BVF Inc
California
+$7.26M
2
EC
EcoR1 Capital
California
+$4.99M
3
BlackRock
BlackRock
New York
+$4.05M
4
N
Nuveen
North Carolina
+$1.34M
5
Morgan Stanley
Morgan Stanley
New York
+$888K

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$16.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$696K
3
AG
Artal Group
Luxembourg
-$300K
4
TI
Trexquant Investment
Connecticut
-$204K
5
Wells Fargo
Wells Fargo
California
-$134K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$553K +$521K +52,018 +297%
Barclays
27
Barclays
United Kingdom
$402K +$402K +40,134 +383%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$391K – – –
OAM
29
Oxford Asset Management
United Kingdom
$378K +$310K +31,012 +188%
Bank of America
30
Bank of America
North Carolina
$366K +$184K +18,419 +67%
MML Investors Services
31
MML Investors Services
Massachusetts
$357K -$64.7K -6,464 -13%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$351K +$46.7K +4,664 +12%
Two Sigma Investments
33
Two Sigma Investments
New York
$349K +$439K +43,883 New
State of Wisconsin Investment Board
34
State of Wisconsin Investment Board
Wisconsin
$344K +$10K +1,000 +2%
Swiss National Bank
35
Swiss National Bank
Switzerland
$343K – – –
B
36
Bailard
California
$304K – – –
Deutsche Bank
37
Deutsche Bank
Germany
$294K -$21K -2,094 -5%
Renaissance Technologies
38
Renaissance Technologies
New York
$275K +$346K +34,600 New
Wells Fargo
39
Wells Fargo
California
$272K -$134K -13,408 -28%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$248K – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$225K +$66.1K +6,600 +30%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$175K +$101K +10,084 +84%
GGHC
43
Gilder Gagnon Howe & Co
New York
$163K +$205K +20,443 New
CSS
44
Cubist Systematic Strategies
Connecticut
$163K +$205K +20,494 New
AIG
45
American International Group
New York
$159K +$370 +37 +0.2%
WPIC
46
White Pine Investment Company
Michigan
$151K +$190K +18,939 New
Jacobs Levy Equity Management
47
Jacobs Levy Equity Management
New Jersey
$144K +$181K +18,076 New
PP
48
PDT Partners
New York
$133K +$167K +16,700 New
GCP
49
GSA Capital Partners
United Kingdom
$129K +$23.9K +2,392 +17%
Russell Investments Group
50
Russell Investments Group
United Kingdom
$128K +$161K +16,037 New
1
2
3 4

RCUS Hedge Fund Activity: Q2 2019 in Review

78 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q2 2019, worth a combined $210M — down 35% from $322M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new RCUS positions and 3 closed out — a net gain of 16 holders — while 27 added to existing stakes and 12 trimmed.

The largest buyer was BVF Inc, adding an estimated $7.26M. The largest seller was Wellington Management Group, cutting an estimated $16.1M.

  • 78 institutional investors held Arcus Biosciences (RCUS) as of Q2 2019, up from 64 in Q1 2019.
  • Funds reported $210M of Arcus Biosciences stock for Q2 2019, down 35% quarter-over-quarter.
  • 19 funds opened new Arcus Biosciences positions in Q2 2019 and 3 closed out, a net change of +16 holders.
  • The largest Arcus Biosciences buyer in Q2 2019 was BVF Inc, an estimated $7.26M added.
  • The largest Arcus Biosciences seller in Q2 2019 was Wellington Management Group, an estimated $16.1M sold.

Based on aggregated 13F filings for Q2 2019.